Latest news
Treating ‘Untreatable’ Diseases: Gene Therapy and the Patent Battlefield
Gene therapy is revolutionising the field of molecular medicine and the capabilities of therapeutic approaches Recent developments demonstrate the potential for gene therapy to address some of… read more…
Mathys & Squire Partners featured in IAM Strategy 300 Global Leaders 2026
Three Mathys & Squire Partners, Anna Gregson, Dani Kramer, and Martin MacLean, have been recognised in the 2026 edition of IAM Strategy 300 Global Leaders The guide acknowledges those that… read more…
Continuing trend of cutting-edge medical technology being used in the cosmetics industry
Partner Samantha Moodie and Associate Clare Pratt have been featured in Life Sciences IP Review and Aesthetic Medicine providing commentary on the increased use of biotherapeutic molecules in… read more…
